Table 1 Demographic and basic clinical and laboratory data in the study cases

Age (Years)

45.55 ± 13.58

Duration since transplantation (Years)

4 (1–8)

Original kidney disease:

Hypertension

42 (70%)

Diabetic kidney disease

12 (20%)

Unknown etiology

9 (15%)

Chronic glomerulonephritis

6 (10%)

Dialysis vintage before transplant (months)

19 ± 8.98

Medications

Low dose corticosteroids

60 (100%)

Mycophenolic acid

42 (70%)

Tacrolimus

36 (60%)

Cyclosporin

24 (40%)

Mycophenolate mofetil

12 (20%)

Everolimus

6 (10%)

Radiocephalic AVF

36 (60%)

Laboratory data

Hemoglobin (g/dl)

13.87 ± 0.73

WBCs X 10⁹ /L

7.46 ± 1.98

Platelets X 10⁹ /L

229 (162–553)

eGFR (ml/min/1.73m²)

85.55 ± 14.73

Creatinine (mg/dl)

1.15 ± 0.14

Corrected calcium (mg/dl)

9.15 ± 0.55

Phosphorous (mg/dl)

3.31 ± 0.63

Total testosterone (ng/ml)

5.17 ± 1.4

Free testosterone (pg/ml)

95.46 ± 28.24

Vitamin D (ng/ml)

16.44 (6.75–29.93)

PTH (pg/ml)

75.4 (32.10- 329.7)

Bone mineral density in the different regions:

Bone mineral density (BMD) of lumbar region

-1.35 (-3.1 : 0.6)

Bone mineral density (BMD) of hip region

-1.20 (-2.7 : 0.7)

Bone mineral density (BMD) of forearm

-2.25 (-5.1 : 2.8)

Overall incidence of osteoporosis and osteopenia

Osteoporosis at any site

27 (45%)

Osteopenia only at any site

27 (45%)

No osteoporosis/osteopenia at any site

6 (10%)